Literature DB >> 8166702

Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein.

N K Gopaul1, J Nourooz-Zadeh, A I Mallet, E E Anggård.   

Abstract

It has been recently reported that a series of prostaglandin F2-like compounds (PGF2-isoprostanes) are produced in vivo by non-enzymatic peroxidation of arachidonic acid. Of these, 8-epi-PGF2 alpha is the major component and has been shown to be a potent vasoconstrictor. Here we investigated the formation of PGF2-isoprostanes during copper-mediated oxidation of low density lipoprotein (LDL). Free and total (sum of free and esterified) levels of PGF2-isoprostanes were measured at times 0, 3, 6, 8 and 24 h, using a solid-phase extraction procedure and gas chromatography-mass spectrometry. In native LDL, free levels of PGF2-isoprostanes were between 0.06 and 0.10 ng/mg protein (n = 4), and the total levels ranged from 0.027 to 0.057 ng/mg protein (n = 4). Free levels of the isoprostanes were found to increase throughout the oxidation, whereas total levels reached a maximum after 3 h then gradually decreased. 8-epi-PGF2 alpha was the major isoprostane formed (free concentration after 24 h 1.8 +/- 0.1 ng/mg protein (n = 4); total concentrations of 8.8 +/- 1.8 and 6.1 +/- 3.6 ng/mg protein (n = 4) after 3 and 24 h, respectively). The levels of isoprostanes correlated well with other indices of lipid peroxidation (conjugated dienes, hydroperoxides, thiobarbituric reactive substances) measured at similar time points. The release of PGF2-isoprostanes from oxidised LDL in macrophages could be a contributory factor in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166702     DOI: 10.1006/bbrc.1994.1453

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial.

Authors:  Christopher Papandreou; Sophia E Schiza; Manolis N Tzatzarakis; Mathaios Kavalakis; Christos M Hatzis; Aristidis M Tsatsakis; Anthony G Kafatos; Nikolaos M Siafakas; Nikolaos E Tzanakis
Journal:  Sleep Breath       Date:  2011-09-15       Impact factor: 2.816

2.  Exposure to traffic emissions: associations with biomarkers of antioxidant status and oxidative damage.

Authors:  Yanli Li; Jing Nie; Jan Beyea; Carole B Rudra; Richard W Browne; Matthew R Bonner; Lina Mu; Maurizio Trevisan; Jo L Freudenheim
Journal:  Environ Res       Date:  2012-11-08       Impact factor: 6.498

3.  Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathy.

Authors:  Helmut Sinzinger; Fahdi Chehne; Graziana Lupattelli
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Levels of TBARS are inversely associated with lowest oxygen saturation in obese patients with OSAS.

Authors:  Christopher Papandreou
Journal:  Sleep Breath       Date:  2013-01-30       Impact factor: 2.816

5.  Whole-body cryostimulation--potential beneficial treatment for improving antioxidant capacity in healthy men--significance of the number of sessions.

Authors:  Anna Lubkowska; Barbara Dołęgowska; Zbigniew Szyguła
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

6.  Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.

Authors:  Janelle L Davis; Hunter L Paris; Joseph W Beals; Scott E Binns; Gregory R Giordano; Rebecca L Scalzo; Melani M Schweder; Emek Blair; Christopher Bell
Journal:  Nutr Metab Insights       Date:  2016-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.